Clinical Trial Update: Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring plasma biomarkers for aflibercept in recurrent or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Yonsei University | Conditions: Recurrent or Metastatic Colorectal Cancer | Phase 4 | Status: UNKNOWN